Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KIAA1199 promotes oxaliplatin resistance and epithelial mesenchymal transition of colorectal cancer via protein O-GlcNAcylation. | Transl Oncol | 2023 | 36610242 | PubTator, text mining | PubMed |
| Exploring PROTAC Cooperativity with Coarse-Grained Alchemical Methods. | J Phys Chem B | 2023 | 36607139 | PubTator, text mining | PubMed |
| Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach. | ACS Chem Biol | 2023 | 36606710 | PubTator, text mining | PubMed |
| E3-Specific Degrader Discovery by Dynamic Tracing of Substrate Receptor Abundance. | J Am Chem Soc | 2023 | 36602777 | PubTator, text mining | PubMed |
| Meeting report: 35th International Conference on Antiviral Research in Seattle, Washington, USA - March 21-25, 2022. | Antiviral Res | 2023 | 36596323 | PubTator, text mining | PubMed |
| Development of potent and selective degraders of PI5P4Kγ. | Eur J Med Chem | 2023 | 36584631 | PubTator, text mining | PubMed |
| Targeted degradation via direct 26S proteasome recruitment. | Nat Chem Biol | 2023 | 36577875 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of novel quinazolinone derivatives as CRBN E3 ligase modulators. | Eur J Med Chem | 2023 | 36577219 | PubTator, text mining | PubMed |
| Targeted protein degradation as an antiviral approach. | Antiviral Res | 2023 | 36567024 | PubTator, text mining | PubMed |
| Discovery of the First Lactate Dehydrogenase Proteolysis Targeting Chimera Degrader for the Treatment of Pancreatic Cancer. | J Med Chem | 2023 | 36538511 | PubTator, text mining | PubMed |
| Development of Epstein-Barr virus-associated lymphoproliferative disorder and hemophagocytic lymphohistiocytosis during long-term lenalidomide maintenance therapy in multiple myeloma. | Int J Hematol | 2023 | 36510096 | PubTator, text mining | PubMed |
| KCa-Related Neurological Disorders: Phenotypic Spectrum and Therapeutic Indications. | Curr Neuropharmacol | 2023 | 36503451 | PubTator, text mining | PubMed |
| Synthesis of novel glutarimide ligands for the E3 ligase substrate receptor Cereblon (CRBN): Investigation of their binding mode and antiproliferative effects against myeloma cell lines. | Eur J Med Chem | 2023 | 36476642 | PubTator, text mining | PubMed |
| Design and characterization of a heterobifunctional degrader of KEAP1. | Redox Biol | 2023 | 36473314 | PubTator, text mining | PubMed |
| Molecular interaction networks and drug development: Novel approach to drug target identification and drug repositioning. | FASEB J | 2023 | 36468661 | PubTator, text mining | PubMed |
| Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid Leukemia. | Cancer Discov | 2023 | 36455613 | PubTator, text mining | PubMed |
| Mutant NPM1 Hijacks Transcriptional Hubs to Maintain Pathogenic Gene Programs in Acute Myeloid Leukemia. | Cancer Discov | 2023 | 36455589 | PubTator, text mining | PubMed |
| Discovery of pan-IAP degraders via a CRBN recruiting mechanism. | Eur J Med Chem | 2023 | 36410083 | PubTator, text mining | PubMed |
| NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts. | Blood | 2023 | 36375120 | PubTator, text mining | PubMed |
| OncoLoop: A Network-Based Precision Cancer Medicine Framework. | Cancer Discov | 2023 | 36374194 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=45